ArticleInternational journal of cancer2007

Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel.

Brunilde Gril et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.